Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (21-30 of 421) with videos related to

Pageof 43
Sort By:
Frontiers of Neurology and Neuroscience|February 3, 2009
The concept of vascular cognitive impairmentTimo Erkinjuntti, Serge Gauthier
Expert Review of Neurotherapeutics|May 4, 2012
Ethical issues in Alzheimer's disease: an overviewAntoine Leuzy, Serge Gauthier
Clinical Interventions in Aging|December 16, 2014
Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trialsSerge Gauthier, Sandra Schlaefke
International Psychogeriatrics|April 18, 2009
Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's diseaseSerge Gauthier, John O'Brien
International Psychogeriatrics|September 30, 2005
Does vascular MCI progress at a different rate than does amnestic MCI?Serge Gauthier, Kenneth Rockwood
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 10, 2009
Can we do better in developing new drugs for Alzheimer's disease?Serge Gauthier, Philip Scheltens
Expert Opinion on Pharmacotherapy|January 16, 2013
A 10-year perspective on donepezilLaksanun Cheewakriengkrai, Serge Gauthier
International Psychogeriatrics|December 13, 2007
Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's diseaseBarry Reisberg, Serge Gauthier
Archives of Neurology|July 13, 2005
Mild cognitive impairment is not a clinical entity and should not be treatedSerge Gauthier, Jacques Touchon
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 2, 2007
Clinical trials in Parkinson's disease dementia and dementia with Lewy bodiesRichard Camicioli, Serge Gauthier
Pageof 43

Showing results (21-30 of 421) with videos related to

Sort By:
Pageof 43
Frontiers of Neurology and Neuroscience|February 3, 2009
The concept of vascular cognitive impairmentTimo Erkinjuntti, Serge Gauthier
Expert Review of Neurotherapeutics|May 4, 2012
Ethical issues in Alzheimer's disease: an overviewAntoine Leuzy, Serge Gauthier
Clinical Interventions in Aging|December 16, 2014
Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trialsSerge Gauthier, Sandra Schlaefke
International Psychogeriatrics|April 18, 2009
Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's diseaseSerge Gauthier, John O'Brien
International Psychogeriatrics|September 30, 2005
Does vascular MCI progress at a different rate than does amnestic MCI?Serge Gauthier, Kenneth Rockwood
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 10, 2009
Can we do better in developing new drugs for Alzheimer's disease?Serge Gauthier, Philip Scheltens
Expert Opinion on Pharmacotherapy|January 16, 2013
A 10-year perspective on donepezilLaksanun Cheewakriengkrai, Serge Gauthier
International Psychogeriatrics|December 13, 2007
Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's diseaseBarry Reisberg, Serge Gauthier
Archives of Neurology|July 13, 2005
Mild cognitive impairment is not a clinical entity and should not be treatedSerge Gauthier, Jacques Touchon
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 2, 2007
Clinical trials in Parkinson's disease dementia and dementia with Lewy bodiesRichard Camicioli, Serge Gauthier
Pageof 43